Cervix News and Research

RSS

Etravirine reduces HIV viral loads when taken with Prezista

The experimental antiretroviral drug etravirine, made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals, greatly reduces HIV viral loads in people with a history of drug resistance when taken in combination with Tibotec's antiretroviral Prezista, according to two studies published Saturday in the journal The Lancet.

10 Jul 2007

Cervarix vaccine provides broad protection against cervical cancer

Just under 150 Perth women have contributed to major international research at the Telethon Institute for Child Health Research that has proved that the new Cervarix vaccine provides broader protection against cervical cancer.

29 Jun 2007

Natural hormone relaxin offers hope to infertile couples

A new study from the University of Leicester is investigating whether a naturally produced hormone could provide the key to helping couples conceive.

29 Jun 2007

International studies show high efficacy for Gardasil

A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer, strains 16 and 18.

1 Jun 2007

Obese women 3.5 times more likely to require a Caesarean

Liverpool scientists have uncovered the reason why overweight women have more Caesarean sections; they are at significant risk of their uterus contracting poorly in childbirth.

19 Apr 2007

Taking a jab at cancer by stimulating the immune system

As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress.

18 Apr 2007

Roche and Transgene S.A. partner on HPV vaccine program

Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.

11 Apr 2007

New screening method for cervical cancer holds promise

A method of screening women in Ghana for early signs of cervical cancer and providing preventive treatment at the same visit appears to be safe, acceptable to women and feasible, according to a study by a researcher at the Stanford University School of Medicine.

2 Apr 2007

Should male circumcision be recommended for the prevention of HIV infection?

In response to the urgent need to reduce the number of new HIV infections globally, WHO and the UNAIDS Secretariat convened an international expert consultation to determine whether male circumcision should be recommended for the prevention of HIV infection.

28 Mar 2007

One in four American women infected with HPV

In the first comprehensive study of a sexually transmitted disease that can cause cervical cancer, it has been found that one in four American women age 14 to 59 are infected with the human papillomavirus (HPV).

28 Feb 2007

High-dose progesterone treatment helps at-risk pregnant women avoid premature delivery

In this study, 45 women who experienced premature labor (before 37 weeks gestation) were randomly divided into treatment and observation groups. The treatment group received twice-weekly 341-mg doses of progesterone until week 36.

11 Feb 2007

Investigational treatment for cervical dysplasia

Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia.

30 Jan 2007

HPV test is a better long-term predictor of cervical cell abnormalities than pap smear

The best initial cervical cancer screening tool for younger women is still the traditional Pap smear. However, a large Danish study has found that for older women (age 40 and older), a test for human papillomavirus (HPV) is a much more effective way to screen for potential cancer.

1 Nov 2006

Fewer deaths from cancer in the U.S.

According to a new report fewer Americans are dying of cancer even though the rates of new cancers remains the same.

7 Sep 2006

Cancer patient receives first proton therapy treatment

A Cocoa Beach man with prostate cancer has become the first patient to undergo treatment at the new University of Florida Proton Therapy Institute, the first time the most advanced form of radiation therapy available has been offered in the Southeast.

15 Aug 2006